Trial of CF101 to Treat Patients With Psoriasis

Mise à jour : Il y a 4 ans
Référence : NCT01265667

Femme et Homme

Extrait

Eligible patients with Psoriasis will be treated with CF101 or placebo twice daily for 16 weeks. All subjects will receive open-lable CF101 in weeks 17-32.


Critère d'inclusion

  • Plaque psoriasis


Liens